About Io Biotech (IOBT)
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disr... Read more
- USD1.59
- USD1.60
- USD1.50
- USD1.73
- 49.50%
- --
- 182.91k
- 208.46k
- 94M
- 0.66
- 28.00%
Stock News
yesterday
U.S. stock futures flat ahead of renewed trade talks with China
MarketWatch
yesterday
Ashland: Time To Rise From Its Ashes
SeekingAlpha
yesterday
Speaker Johnson hopes Musk and Trump can 'reconcile' their differences after public fallout
CNBC
yesterday
Innoviva: A Riddle Wrapped In A Mystery Inside An Enigma
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
